Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Triple Negative Breast Neoplasms
×
magrolimab
×
Clear all
Filters
3
NCT04958785
2025-11-04
ELEVATE TNBC
Gilead Sciences
Phase 2
Terminated
92 enrolled
27 charts